NCT07585630Not yet recruitingPhase 2
A1Cantus vs. Placebo
Double-Blind Randomized Controlled Trial of A1Cantus Drink vs. Placebo for Reduction of Ha1c
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 7 May 2026
- Start date
- 15 Jun 2026
- Primary completion date
- 15 Dec 2027
- Lead sponsor
- University of California, Riverside
- Diseases
- Type 2 diabetes
- NCT number
- NCT07585630
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 50
- From 15 Jun 2026 to the primary completion date, 15 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk \> 5, or history of CVD/stroke
- Allergic to cinnamon
- Severe diseases, such as cancer
- Eating disorders
- Substance use disorder
Age
- Patients \<21 years of age, who do not have type II DM, whose Ha1c is less than 8 or \> 10,
Other
- Do not speak and understand either English or Spanish well
- Compromised immune system
- BMI of 40 or higher
- Already have a family member participating in the study
Who the study is looking for
- Adults 21 years of age or older and not older than 75 recruited from UCR Health
- Clinical diagnosis of type II DM with Ha1c \>= 8 but less than or equal to 10
- Stable medications for at least 6 months
- Speak Spanish and/or English
- Sign an informed consent form
- No other members in their household are participating in the study
Age in the registry: 21 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCR Health Coordinator of this site? Confirm its status | Riverside | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.